Activist Investors Bid $2.25 Per Share to Take Over SEER
Activist investors offer to buy Seer for $2.25/share cash + CVR, criticize CEO, and push board to respond by Apr 22.
Activist investors offer to buy Seer for $2.25/share cash + CVR, criticize CEO, and push board to respond by Apr 22.
Somnigroup is buying Leggett & Platt in a $2.5B stock deal to cut costs, grow faster, and expand beyond mattresses.
Canaccord says Biohaven is undervalued and could rise on epilepsy trial results. Jefferies likes Caris Life Sciences and Veracyte, citing strong growth in cancer diagnostics and solid finances.
Roblox adds safer kids accounts with age checks, limited chat, and stricter rules to protect young players from online risks.
TD Cowen upgraded Tempus AI to Buy, $65 target, citing strong growth in AI pharma tools despite recent stock drop.
IKS nearing $600M buy of TruBridge to boost US healthcare billing/RCM, expand AI-driven services and market share.